Abstract:Bile acids (BAs) are steroid detergents in bile that contribute to the absorption of fats and fat-soluble vitamins while shaping the gut microbiome because of their antimicrobial properties 1,2,3,4 . Here we identify the enzyme responsible for a mechanism of BA metabolism by the gut microbiota involving amino acid conjugation to the acyl-site of BAs, thus producing a diverse suite of microbially conjugated bile acids (MCBAs). We show that this transformation is mediated by acyltransferase activity of bile salt hydrolase (bile salt hydrolase/transferase, BSH/T). Clostridium perfringens BSH/T rapidly performed acyl transfer when provided various amino acids and taurocholate, glycocholate or cholate, with an optimum at pH 5.3. Amino acid conjugation by C. perfringens BSH/T was diverse, including all proteinaceous amino acids except proline and aspartate. MCBA production was widespread among gut bacteria, with strain-specific amino acid use. Species with similar BSH/T amino acid sequences had similar conjugation profiles and several bsh/t alleles correlated with increased conjugation diversity. Tertiary structure mapping of BSH/T followed by mutagenesis experiments showed that active site structure affects amino acid selectivity. These MCBA products had antimicrobial properties, where greater amino acid hydrophobicity showed greater antimicrobial activity. Inhibitory concentrations of MCBAs reached those measured natively in the mammalian gut. MCBAs fed to mice entered enterohepatic circulation, in which liver and gallbladder concentrations varied depending on the conjugated amino acid. Quantifying MCBAs in human faecal samples showed that they reach concentrations equal to or greater than secondary and primary BAs and were reduced after bariatric surgery, thus supporting MCBAs as a significant component of the BA pool that can be altered by changes in gastrointestinal physiology. In conclusion, the inherent acyltransferase activity of BSH/T greatly diversifies BA chemistry, creating a set of previously underappreciated metabolites with the potential to affect the microbiome and human health.

Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis

Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System

The changing metabolic landscape of bile acids – keys to metabolism and immune regulation

Consequences of bile salt biotransformations by intestinal bacteria

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets

Bile Acid Physiology

Bile Acids-A Peek Into Their History and Signaling

Bile Acids: A Communication Channel in the Gut-Brain Axis

Bile acids: emerging role in management of liver diseases

Bile acids are nutrient signaling hormones

The emerging role of bile acids as critical components in nanotechnology and bioengineering: Pharmacology, formulation optimizers and hydrogel-biomaterial applications

Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders

Biological Functions and Pharmacological Behaviors of Bile Acids in Metabolic Diseases.

A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling

Bile acids as regulatory molecules and potential targets in metabolic diseases

Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients

Dietary polyphenols maintain homeostasis <i>via</i> regulating bile acid metabolism: a review of possible mechanisms

Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease

Bile salt hydrolase acyltransferase activity expands bile acid diversity

Bile acids regulate cardiovascular function